Five new hospitals have implemented the Daxor Corporation’s BVA-100 blood volume diagnostic for clinical use to guide fluid management in heart failure patients during the first quarter of 2023
Daxor Corporation, the global leader in blood volume measurement technology, today announces new data validating the benefits of the Company's BVA-100 diagnostic blood test in reducing hospital length of stay (LOS) for heart failure (HF) patients.